High Growth Tech Stocks to Watch in the US in August 2025

In the US stock market, high growth tech stocks remain a focus for investors despite volatility. The top 10 high growth tech companies include ADMA Biologics, Palantir Technologies, Workday, Circle Internet Group, and RenovoRx, among others. These companies have shown significant revenue and earnings growth, with some having a growth rating of 5 stars. Aldeyra Therapeutics, for example, is expected to have a 74.8% annual profit increase and a 42.9% revenue growth forecast, outpacing the US market average.

The US stock market continues to experience fluctuations, with the Dow retreating from record highs and investors closely monitoring Nvidia's earnings amidst broader economic signals. Despite the volatility, high-growth tech stocks remain a focal point for many investors due to their potential for rapid growth and innovation. As of August 2025, several companies have demonstrated strong fundamentals and adaptability to market changes, positioning them as promising investments.

Among the top 10 high-growth tech companies in the US market, ADMA Biologics, Palantir Technologies, and Workday stand out for their robust revenue and earnings growth. ADMA Biologics, for instance, reported a 20.6% revenue growth and a 23.25% earnings growth, while Palantir Technologies showed a 25.25% revenue growth and a 31.57% earnings growth [2]. Workday, on the other hand, achieved an 11.49% revenue growth and a 29.77% earnings growth [2].

Circle Internet Group and RenovoRx also exhibit impressive growth metrics. Circle Internet Group reported a 27.36% revenue growth and a 78.79% earnings growth, while RenovoRx showed a 65.52% revenue growth and a 68.83% earnings growth [2]. These companies, along with others such as Vanda Pharmaceuticals and Gorilla Technology Group, have shown significant potential in their respective sectors.

In addition to these companies, biotech and healthcare stocks have also gained attention. Dynavax Technologies, for example, raised its 2025 revenue guidance to between $315 million and $325 million following strong first-half performance [1]. Exelixis, Inc., an oncology company, demonstrated resilience with a 72.1% earnings growth over the past year, despite a recent dip in quarterly revenue [1].

Phreesia, Inc., a SaaS-based software and payment platform for the healthcare sector, generated $434.53 million in revenue from its healthcare software segment [1]. The company's business model focuses on providing integrated solutions to the healthcare industry in North America, positioning it as a key player in the sector.

In conclusion, the US stock market continues to present opportunities for investors in high-growth tech stocks. Companies like ADMA Biologics, Palantir Technologies, Workday, Circle Internet Group, and RenovoRx, among others, have shown significant revenue and earnings growth, making them attractive investment options. As the market evolves, these companies are well-positioned to capitalize on emerging technologies and market trends.

References:

[1] https://finance.yahoo.com/news/high-growth-tech-stocks-us-114135128.html
[2] https://simplywall.st/stocks/us/healthcare/nyse-phr/phreesia/news/high-growth-tech-stocks-in-the-us-market-to-watch-2